AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12576938
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic therapy with filgrastim
Trial: 10389953
Drug: 0.9 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg/kg intravenous (IV) ketorolac
Trial: 3729509
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution
Trial: 6849731
Drug: Chlordiazepoxide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlordiazepoxide (25 mg)
Trial: 23524015
Drug: FP/S 500/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP/S 500/100 μg/day Diskus®
Trial: 20975611
Drug: No angiotensin-converting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No angiotensin-converting enzyme inhibitor group
Trial: 19118243
Drug: High-dose B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose B vitamin supplementation (5 mg folic acid + 0.4 mg vitamin B12 + 50 mg vitamin B6)
Trial: 18854539
Drug: High-dose B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose B vitamin supplementation
Trial: 17159081
Drug: Aliskiren +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren + Hydrochlorothiazide (150 mg + 25 mg)
Trial: 15120684
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam prophylaxis
Trial: 15120684
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral prophylaxis (Control)
Trial: 11100761
Drug: Low-dose nitroglycerin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nitroglycerin (3 microg per kg heart weight per min)
Trial: 11100761
Drug: Bolus nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus nitroglycerin (2 mg into the aortic root)
Trial: 18503141
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nitrendipine
Trial: 8249556
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg nitrendipine
Trial: 3698063
Drug: Rociverine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rociverine (20 mg)
Trial: 15002318
Drug: berlition 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: berlition 300 oral
Trial: 2186623
Drug: 0.5% podofilox
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% podofilox solution
Trial: 29958027
Drug: Multimicronutrient syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimicronutrient syrup
Trial: 28435031
Drug: Metered-dose-inhaler with
RxNorm normalized name: Primatene with ephedrine 0.125 MG/ACTUAT Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose-inhaler with AeroChamber Vent (MDI-AV) with humidification
Trial: 28435031
Drug: Metered-dose-inhaler with
RxNorm normalized name: Primatene with ephedrine 0.125 MG/ACTUAT Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose-inhaler with AeroChamber Vent (MDI-AV) without humidification
Trial: 22441962
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise (submaximal treadmill walking, 30 min daily, 3 times a week for 6 weeks)
Trial: 21309695
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (15 mg every morning or two times per day as glycinate)
Trial: 21309695
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (15 mg b.i.d.)
Trial: 31827626
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg/day)
Trial: 16433205
Drug: Celecoxib (CE)
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib (CE) 200 mg
Trial: 9016418
Drug: Warfarin for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin for 85-year-old patients
Trial: 9016418
Drug: Warfarin for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin for patients with bleeding risk factors
Trial: 9016418
Drug: Warfarin prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin prescription by physicians with favorable opinions
Trial: 9016418
Drug: Warfarin prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin prescription despite good experience and favorable opinions
Trial: 1611986
Drug: Midazolam (Dormicum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (Dormicum 7.5 mg)
Trial: 24450992
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CDSMP + PDA (n = 99)
Trial: 22834932
Drug: Sham-laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-laser treatment + SRP
Trial: 18681820
Drug: Sertraline (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (up to 50 or 100 mg/day)
Trial: 11006058
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive and estrogen replacement therapy users
Trial: 29198064
Drug: Tablet (200-μg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet (200-μg)
Trial: 27981529
Drug: 100 mg/d
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/d regular oral intake of aspirin
Trial: 24239210
Drug: Concurrent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent treatment (paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab)
Trial: 29855294
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment
Trial: 2690739
Drug: Mother's expressed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mother's expressed milk with banked milk supplement
Trial: 1131298
Drug: Freshly extracted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freshly extracted juice of 50 g of garlic
Trial: 27586512
Drug: Dexmedetomidine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine and analgesics for 72 hours after abdominal operations
Trial: 27586512
Drug: Only analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only analgesics
Trial: 26884660
Drug: Intravenous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthesia (ketamine-propofol) only (Control)
Trial: 23406536
Drug: Deflazacort (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort (1 mg/kg/day in month one, 1 mg/kg every 2nd day during months two to six)
Trial: 21931864
Drug: Intraduodenal pea
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal pea protein administration (250 mg/kg bodyweight in 0.4 ml/kg bodyweight of water)
Trial: 21931864
Drug: Intraduodenal pea
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal pea protein administration
Trial: 21931864
Drug: Placebo (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.4 ml/kg bodyweight of water)
Trial: 21931864
Drug: Oral pea
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pea protein administration
Trial: 20029895
Drug: Pattern-mixture zero-inflated
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pattern-mixture zero-inflated model with compound Poisson random effects
Trial: 15272628
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose solution (placebo)
Trial: 15272628
Drug: Intravenous cytoflavin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cytoflavin
Trial: 11232022
Drug: Transdermal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal administration of 100 microgram/day estradiol (E(2)) for 2 days
Trial: 1425532
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (individual counselling)
Trial: 1425532
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (group therapy)
Trial: 1425532
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (school health care setting)
Trial: 4011126
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate (500 mg, 3 times daily for 3 months)
Trial: 29866199
Drug: Prescription hydration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription hydration plan (PHP)
Trial: 19398690
Drug: Electronic health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic health record enhancement (smoking status icons, tobacco treatment reminders, Tobacco Smart Form)
Trial: 11786563
Drug: Adenosine 5'‐triphosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 5'‐triphosphate (ATP) infusion (10 intravenous, 30‐hour infusions every 2 to 4 weeks)
Trial: 15565568
Drug: Tamoxifen alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen alone (30 mg/d orally)
Trial: 2905632
Drug: Neuroleptic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic therapy in schizophrenics with affective heredity
Trial: 2905632
Drug: Neuroleptic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic therapy in schizophrenics with schizophrenic heredity
Trial: 22171201
Drug: Exposure, Relaxation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure, Relaxation, and Rescripting Therapy (ERRT)
Trial: 25320361
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg/day
Trial: 18283233
Drug: Cefuroxime IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime IV 750 mg tid for 3 days followed by cefuroxime-axetil PO 500 mg bid for 7 days
Trial: 10378132
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of azithromycin as a single dose
Trial: 10378132
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of azithromycin once daily for 3 days
Trial: 6630540
Drug: Self-administered cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered cognitive therapy (RET)
Trial: 6630540
Drug: Self-administered attention
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered attention placebo condition (Logo-therapy)
Trial: 7610222
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control condition
Trial: 15747805
Drug: Computer-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based treatment focusing on phonological and morphological structure of Dutch words
Trial: 15747805
Drug: Computer-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based treatment
Trial: 12125829
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy intervention program (8 weeks)
Trial: 10220188
Drug: Pneumatic foot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumatic foot compression combined with low-molecular-weight heparin for approximately 7 days after surgery
Trial: 10220188
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (control group)
Trial: 8570764
Drug: Intravenous diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diazepam (5 mg) pretreatment
Trial: 8759084
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg aspirin
Trial: 31267502
Drug: RTS,S/AS01 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 vaccine without booster
Trial: 31267502
Drug: RTS,S/AS01 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS01 vaccine with booster
Trial: 25885011
Drug: augmented treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: augmented treatment (stimulant + parent training + risperidone)
Trial: 25885011
Drug: basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: basic treatment (stimulant + parent training + placebo)
Trial: 25885011
Drug: augmented treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: augmented treatment
Trial: 9374341
Drug: Nalmefene (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene (1 mg or 1 microg/kg)
Trial: 20507387
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immunoglobulin (HD-IVIG) at a dosage of 400 mg/kg per day for 5 days as an adjuvant therapy with systemic steroid therapy and/or immunosuppressive agents.
Trial: 3440636
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg
Trial: 8426316
Drug: Monofocal implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monofocal implant (Group 1)
Trial: 8426316
Drug: Multifocal implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifocal implant (Group 2)
Trial: 3501902
Drug: Dipyridamole (DP)
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole (DP) 75 mg and Acetylsalicylic acid (ASA) 325 mg thrice daily for 3 months
Trial: 29055624
Drug: Cumulative illness
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative illness rating scale‐geriatrics (CIRS‐G)
Trial: 29055624
Drug: Instrumental activities
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instrumental activities of daily living (IADL) from GA
Trial: 27865535
Drug: Intratympanic methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic methylprednisolone (62.5 mg/mL)
Trial: 27865535
Drug: Intratympanic gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intratympanic gentamicin (40 mg/mL)
Trial: 22902096
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg daily)
Trial: 20863398
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement (IS) - 20 mg iron
Trial: 20863398
Drug: Iron +
RxNorm normalized name: Celebrate Iron + C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron + folic acid supplement (IFS) - 12.5 mg iron
Trial: 20863398
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient supplement (MMS) - 10 mg iron
Trial: 20863398
Drug: Micronutrient-fortified complementary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient-fortified complementary food (FCF) - 10 mg iron
Trial: 20863398
Drug: Zinc +
RxNorm normalized name: GNP Cal Mag Zinc + D Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc + iron + ascorbic acid fortified water (FW) - 6.7 mg iron
Trial: 12916465
Drug: Multimodality treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodality treatment
Trial: 8979323
Drug: Specific, localized,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific, localized, exercise therapy
Trial: 1490530
Drug: Continuous bronchodilator
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous bronchodilator treatment
Trial: 1490530
Drug: Symptomatic bronchodilator
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic bronchodilator treatment
Trial: 3874038
Drug: Sulindac sulfoxide
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulindac sulfoxide (200 mg b.i.d.)
Trial: 3874038
Drug: Sulindac sulfide
RxNorm normalized name: Sulindac sulfide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac sulfide (100 mg b.i.d.)
Trial: 3874038
Drug: Aspirin (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (650 mg q.i.d.)
Trial: 27375126
Drug: Universal door-to-door
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Universal door-to-door delivery of HIV testing and referral to prevention and treatment services with immediate offer of anti-retroviral treatment regardless of clinical status
Trial: 27375126
Drug: Universal door-to-door
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Universal door-to-door delivery of HIV testing and referral to prevention and treatment services with offer of treatment in-line with national guidelines
Trial: 24807330
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Indomethacin and antibiotics vs Control)
Trial: 15860753
Drug: Salmeterol in
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol in combination with FP
Trial: 12190841
Drug: E2 1
RxNorm normalized name: PGE2 10 MG Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 1 mg daily plus intermittent NGM 90 micro g (3 days off, 3 days on)
Trial: 12190841
Drug: E2 2
RxNorm normalized name: PGE2 20 MG Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 2 mg plus constant NETA 1 mg daily
Trial: 10530636
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride (50 to 150 mg/d)
Trial: 6988942
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg 3 times a day and 400 mg nocte (standard dose)
Trial: 28118062
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (500 mg three times per day for two weeks)
Trial: 19233765
Drug: Intermittent antegrade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent antegrade blood cardioplegia with 300 mg of NAC
Trial: 17578983
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection group (droperidol 2.5 mg)
Trial: 17578983
Drug: Continuous group
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous group (droperidol 1.25 mg/day)
Trial: 30747707
Drug: On-demand treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand treatment (ODT) with vWF/FVIII concentrates
Trial: 29437056
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g intra-articularly after closure of the wound
Trial: 29437056
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 10 mg/kg IV
Trial: 20124114
Drug: 1.2-g/d omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2-g/d omega-3 PUFA
Trial: 11920412
Drug: Infliximab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5 mg/kg, intravenous loading dose at weeks 0, 2, and 6)
Trial: 15374786
Drug: Tirofiban plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban plus heparin
Trial: 31037994
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg daily
Trial: 21499703
Drug: Gefarnate 50
RxNorm normalized name: gefarnate
DrugBank: Gefarnate (DB12079)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefarnate 50 mg twice daily
Trial: 31613432
Drug: Conservative oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative oxygen therapy
Trial: 24480677
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg tofacitinib
Trial: 24480677
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg tofacitinib
Trial: 24480677
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg tofacitinib
Trial: 21761705
Drug: Oral antihistamine
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antihistamine 10 mg everyday for one week (group CA)
Trial: 21761705
Drug: No loratadine
RxNorm normalized name: Loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No loratadine tablets 10 mg everyday for one week (group CB)
Trial: 16151422
Drug: Busulfan 16
RxNorm normalized name: Busulfan
DrugBank: Busulfan (DB01008)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Busulfan 16 mg/kg + cyclophosphamide 200 mg/kg + antilymphocyte globulin
Trial: 12875349
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (generic gliclazide)